Prevalence of obesity has increased over the past few years and is still growing. Usually obesity is accompanied by co-morbid conditions which may be caused because of it too. Due to this it is not unusual for a physician to have a lot of obese patients. Now, the dosing of the drug is a major issue. The dose given for normal patients may not be accurate for obese patients and it is highly likely to worsen the condition of the patient on account of the fact that pharmacokinetic parameters of an obese individual differs from a normal person. During clinical trials, the dose is calculated for normal weight patients, but the scenario changes in obese. Due to the lack of sufficient evidence, the dose modification poses to be a threat to patients especially the ones who are on drugs with a narrow therapeutic index. Various scales have been formulated to help but more research needs to be done to get precise doses
